As on Thursday, ENDRA Life Sciences Inc (NASDAQ: NDRA) started slowly as it slid -7.37% to $0.21, before settling in for the price of $0.23 at the close. Taking a more long-term approach, NDRA posted a 52-week range of $0.21-$139.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -20.00%. Meanwhile, its Annual Earning per share during the time was 48.47%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 85.97%. This publicly-traded company’s shares outstanding now amounts to $18.14 million, simultaneously with a float of $18.10 million. The organization now has a market capitalization sitting at $3.83 million. At the time of writing, stock’s 50-day Moving Average stood at $2.1726, while the 200-day Moving Average is $29.6415.
ENDRA Life Sciences Inc (NDRA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Diagnostics & Research industry. ENDRA Life Sciences Inc’s current insider ownership accounts for 0.21%, in contrast to 1.15% institutional ownership. According to the most recent insider trade that took place on Aug 27 ’24, this organization’s 10% Owner bought 3,715 shares at the rate of 0.55, making the entire transaction reach 2,052 in total value, affecting insider ownership by 146,012.
ENDRA Life Sciences Inc (NDRA) Earnings and Revenue Records
ENDRA Life Sciences Inc’s EPS increase for this current 12-month fiscal period is 85.97% and is forecasted to reach -8.91 in the upcoming year.
ENDRA Life Sciences Inc (NASDAQ: NDRA) Trading Performance Indicators
Let’s observe the current performance indicators for ENDRA Life Sciences Inc (NDRA). It’s Quick Ratio in the last reported quarter now stands at 4.97. The Stock has managed to achieve an average true range (ATR) of 0.17.
In the same vein, NDRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -44.13, a figure that is expected to reach -1.78 in the next quarter, and analysts are predicting that it will be -8.91 at the market close of one year from today.
Technical Analysis of ENDRA Life Sciences Inc (NDRA)
Through scrutinizing the latest numbers posted by the [ENDRA Life Sciences Inc, NDRA], it can be observed that its last 5-days Average volume of 1.43 million was better the volume of 1.3 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 11.36% While, its Average True Range was 0.0913.
Raw Stochastic average of ENDRA Life Sciences Inc (NDRA) in the period of the previous 100 days is set at 0.01%, which indicates a major fall in contrast to 0.62% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 52.09% that was lower than 273.01% volatility it exhibited in the past 100-days period.
